Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Medication nonadherence is a known behavioural contributor to poor blood pressure (BP) control that puts patients with hypertension at elevated cardiovascular risk. Studies of medication adherence for apparent treatment-resistant hypertension (aTRH) vary significantly with respect to design, methods, and setting, and, as a result, have produced highly variable figures describing the prevalence of nonadherence. This review aimed to describe the prevalence and potential moderators of medication nonadherence estimates for aTRH. METHODS: Systematic review and random effects meta-analysis. RESULTS: From an initial discovery of 921 studies, we identified 24 studies that measured medication adherence for patients with uncontrolled BP despite being prescribed three or more antihypertensive medications of different classes. By using a random effects model, the pooled prevalence of nonadherence was 31.2% (95% confidence interval = 20.2-44.7, I = 99.50) with nonadherence rates ranging from 3.3 to 86.1%. The strongest contributor to variance in nonadherence rates was the method of adherence assessment used. Studies that relied on self-report measures of adherence and/or pharmacy data reported lower levels of nonadherence than studies using more objective methods, such as liquid chromatography-mass spectrometry in single time-point bioassays or directly observed therapy. CONCLUSION: Findings indicate that medication nonadherence is a significant problem among aTRH patients. Identifying the most accurate and clinically feasible adherence assessment methods is necessary to reduce BP and cardiovascular morbidity, facilitate early behavioural intervention, prevent unnecessary diagnostic testing, and limit sometimes unnecessary and expensive BP lowering procedures. REGISTRATION NUMBER: CRD42016028121.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sanderson, S., Tatt, I. D., & Higgins, J. P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym018 · Cited by 1,531 · cited 1×
“[11] in their review of quality and risk of bias assessment tools for observational studies.”
BackgroundMazzaglia, G., Ambrosioni, E., Alacqua, M., Filippi, A., Sessa, E., Immordino, V., Borghi, C., Brignoli, O., Caputi, A. P., Cricelli, C., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.830299 · Cited by 637 · cited 1×
“com observed therapy; ESC, European Society of Cardiology; ESH, European Society of Hypertension; MEDAL, Medication Adherence Across the Lifespan; MEMS, medication event monitoring system; MPR, medication possession ratio; PRISMA, Preferred Reporting Items for Systematic reviews and Meta-Analyses; PROSPERO, Internatio…”
BackgroundDrug adherence in hypertension: from methodological issues to cardiovascular outcomes
Hamdidouche, I., Jullien, V., Boutouyrie, P., Billaud, E., Azizi, M., & Laurent, S. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001299 · Cited by 111
Medication adherence and resistant hypertension
Hyman, D. J., & Pavlik, V (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2014.73 · Cited by 61 · cited 1×
“5% [8]); however, these only report on three common studies, and do not report how or why individual studies were selected for review and therefore, may provide an arbitrary selection of the available evidence.”
BackgroundDillon, M. P., Fatone, S., & Quigley, M. (2016) · Systematic Reviews · doi:10.1186/s13643-015-0171-7 · Cited by 48
Grigoryan, L., Pavlik, V. N., & Hyman, D. J. (2013) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2013.06.004 · Cited by 48
Cited by
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
Self-citationRabi, D. M., McBrien, K. A., Sapir-Pichhadze, R., Nakhla, M., Ahmed, S. B., Dumanski, S. M., Butalia, S., Leung, A. A., Harris, K. C., Cloutier, L., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.02.086 · Cited by 583
Improving blood pressure control using digital communication methods in Serbia
Tasic, N., Tasic, D., Kovacevic, Z., Filipovic, M., Arsic, M., Bozovic-Ogarevic, S., Despotovic, B., Bojic, M., Maksimovic, Z., Zdravkovic, N., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12040914 · Cited by 1
“To the best of our knowledge, this is the first study of the implementation of new technologies for HTA management and CVD risk factors reduction in the Republic of Serbia.”
BackgroundInfluential
Metadata
- Authors
- Durand, H., Hayes, P., Morrissey, E. C., Newell, J., Casey, M., Murphy, A. W., & Molloy, G. J.
- Venue
- Journal of Hypertension
- Published
- 2017-12
- Volume
- 35
- Issue
- 12
- Pages
- 2346-2357
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W2742167604
- Cited by
- 194
- References
- 6
- FWCI
- 16.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis. https://app.cochat.ai/papers/10.1097/hjh.0000000000001502
- The paper
- Durand, H., Hayes, P., Morrissey, E. C., Newell, J., Casey, M., Murphy, A. W., & Molloy, G. J. (2017). Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis. Journal of Hypertension. https://doi.org/10.1097/hjh.0000000000001502
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.